Drug-eluting stents for secondary prevention of restenosis

Catheter Cardiovasc Interv. 2004 Nov;63(3):265-6. doi: 10.1002/ccd.20199.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Coronary Restenosis / prevention & control*
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Sirolimus / administration & dosage
  • Stents*

Substances

  • Immunosuppressive Agents
  • Sirolimus